Search Results - "Laskey, Sarah B"
-
1
Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure
Published in Cell (24-10-2013)“…Antiretroviral therapy fails to cure HIV-1 infection because latent proviruses persist in resting CD4+ T cells. T cell activation reverses latency, but <1% of…”
Get full text
Journal Article -
2
A mechanistic theory to explain the efficacy of antiretroviral therapy
Published in Nature reviews. Microbiology (01-11-2014)“…Combination antiretroviral therapy (cART) has revolutionized the treatment of HIV-1 infection, but the mechanistic basis of successful treatment is poorly…”
Get full text
Journal Article -
3
Evaluating Clonal Expansion of HIV-Infected Cells: Optimization of PCR Strategies to Predict Clonality
Published in PLoS pathogens (01-08-2016)“…In HIV-infected individuals receiving suppressive antiretroviral therapy, the virus persists indefinitely in a reservoir of latently infected cells. The…”
Get full text
Journal Article -
4
Cross-reactive microbial peptides can modulate HIV-specific CD8+ T cell responses
Published in PloS one (21-02-2018)“…Heterologous immunity is an important aspect of the adaptive immune response. We hypothesized that this process could modulate the HIV-1-specific CD8+ T cell…”
Get full text
Journal Article -
5
Re-evaluating evolution in the HIV reservoir
Published in Nature (London) (23-11-2017)Get full text
Journal Article -
6
Identifying Ashkenazi Jewish BRCA1/2 founder variants in individuals who do not self-report Jewish ancestry
Published in Scientific reports (06-05-2020)“…Current guidelines recommend BRCA1 and BRCA2 genetic testing for individuals with a personal or family history of certain cancers. Three BRCA1/2 founder…”
Get full text
Journal Article -
7
Defective proviruses rapidly accumulate during acute HIV-1 infection
Published in Nature medicine (01-09-2016)“…Bruner et al . report that defective HIV-1 proviruses predominate in early infection, even when antiretroviral therapy is initiated in the first months after…”
Get full text
Journal Article -
8
Quantitative evaluation of the antiretroviral efficacy of dolutegravir
Published in JCI insight (17-11-2016)“…The second-generation HIV-1 integrase strand transfer inhibitor (InSTI) dolutegravir (DTG) has had a major impact on the treatment of HIV-1 infection. Here we…”
Get full text
Journal Article -
9
Potent Inhibitors Active against HIV Reverse Transcriptase with K101P, a Mutation Conferring Rilpivirine Resistance
Published in ACS medicinal chemistry letters (08-10-2015)“…Catechol diether compounds have nanomolar antiviral and enzymatic activity against HIV with reverse transcriptase (RT) variants containing K101P, a mutation…”
Get full text
Journal Article -
10
Cross-reactive microbial peptides can modulate HIV-specific CD8.sup.+ T cell responses
Published in PloS one (21-02-2018)“…Heterologous immunity is an important aspect of the adaptive immune response. We hypothesized that this process could modulate the HIV-1-specific CD8.sup.+ T…”
Get full text
Journal Article -
11
Re-evaluating evolution in the HIV reservoir/Lorenzo-Redondo et al. reply
Published in Nature (London) (23-11-2017)“…Despite antiretroviral therapy (ART), a latent reservoir of replication-competent HIV-1 persists in resting memory CD4+ T cells and precludes a cure1-6…”
Get full text
Journal Article -
12
Replication-competent non-induced proviruses in the latent reservoir increase barrier to HIV-1 cure
Published in Cell (24-10-2013)Get full text
Journal Article